Literature DB >> 1765650

The JAM test. A simple assay for DNA fragmentation and cell death.

P Matzinger1.   

Abstract

Most current methods for measuring cell death are based on plasma membrane disintegration and the consequent release of cytoplasm. The relevant cells are usually loaded with a label (usually 51Cr or 125I), the release of which is measured. I describe here a method, based on the recent evidence that dying cells often degrade their DNA into small fragments, which measures the DNA retained by living cells rather than the cellular components lost by dying cells. The assay is set up essentially like the current cell lysis assays and harvested like a cell proliferation assay. It is faster, more sensitive, easier to set up, less expensive and safer than the current standard 51Cr release assay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765650     DOI: 10.1016/0022-1759(91)90325-a

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  113 in total

1.  Intraepithelial and lamina propria lymphocytes show distinct patterns of apoptosis whereas both populations are active in Fas based cytotoxicity in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; S D'Alò; R Parroni; D Millimaggi; M G Cifone; G R Corazza
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.

Authors:  Elaine J Schattner; Steven M Friedman; Paolo Casali
Journal:  Autoimmunity       Date:  2002-07       Impact factor: 2.815

3.  Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells.

Authors:  R E Tascon; S Ragno; D B Lowrie; M J Colston
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  In vitro induction of anterior gradient-2-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses as a potential therapy for colorectal cancer.

Authors:  Hyun Ju Lee; Cheol Yi Hong; Mi Hyun Kim; Youn Kyung Lee; Thanh Nhan Nguyen-Pham; Byoung Chul Park; Deok Hwan Yang; Ik Joo Chung; Hyeoung Joon Kim; Je Jung Lee
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

5.  Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Authors:  Rachel A Reboulet; Cassandra M Hennies; Zacarias Garcia; Stefan Nierkens; Edith M Janssen
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

6.  Lack of activation induced cell death in human T blasts despite CD95L up-regulation: protection from apoptosis by MEK signalling.

Authors:  L S Walker; J D McLeod; G Boulougouris; Y I Patel; C N Ellwood; N D Hall; D M Sansom
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

7.  Liposome reconstitution of a minimal protein-mediated membrane fusion machine.

Authors:  Deniz Top; Roberto de Antueno; Jayme Salsman; Jennifer Corcoran; Jamie Mader; David Hoskin; Ahmed Touhami; Manfred H Jericho; Roy Duncan
Journal:  EMBO J       Date:  2005-08-04       Impact factor: 11.598

8.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

9.  Anti-tumor immunostimulatory effect of heat-killed tumor cells.

Authors:  Taek Joon Yoon; Ji Yeon Kim; Hyojeong Kim; Changwan Hong; Hyunji Lee; Chang Kwon Lee; Kwang Ho Lee; Seokmann Hong; Se Ho Park
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

10.  Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo.

Authors:  Chengwen Li; Matthew Hirsch; Aravind Asokan; Brian Zeithaml; Hong Ma; Tal Kafri; R Jude Samulski
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.